Mpox News and Research

Latest Mpox News and Research

Study suggests a single dose of JYNNEOS vaccine may lessen the severity of mpox illness

Researchers pursued evidence that the JYNNEOS vaccine offered some protection against the mpox disease, especially they confirmed the duration for which the one dose of this vaccine conferred protection.

3 Jan 2023

Diagnostic technologies in Asia Pacific are key to progress toward health-related SDGs

We are at the halfway point from when we set our ambitious sustainable development goal 3 (SDG3) for good health and well-being by 2030.

23 Dec 2022

Novel mRNA-lipid nanoparticle vaccine encoding four mpox virus surface proteins generates robust immune responses against orthopoxviruses

Researchers described a messenger ribonucleic acid (mRNA)-lipid nanoparticle monkeypox vaccine encoding four conserved monkeypox virus surface proteins which induced monkeypox virus-specific immunity and elicited heterologous protection when challenged with lethal vaccinia virus.

23 Dec 2022

Single-dose smallpox vaccine could be effective against mpox

Researchers estimated the efficacy of a single-dose Modified Vaccinia Ankara-Bavaria Nordic (MVA-BN) vaccine against mpox (MPX) in gay, bisexual, and other men who have sex with men (GBMSM).

19 Dec 2022

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

A new Eurosurveillance study investigated the efficacy of the MVA-BN vaccine, which was administered to individuals after exposure to the virus.

18 Dec 2022

Cryo-microscopy reveals high-resolution structure of monkeypox virus DNA polymerase holoenzyme

Using cryo-microscopy, researchers present a high-resolution structure of monkeypox virus DNA polymerase holoenzyme, a complex that plays a key role in the genome replication process of the virus.

16 Dec 2022

The mpox viral load kinetics over time in various parts of the body

Researchers characterized the time to mpox virus clearance of immunocompetent individuals with mild MPX in a real-world community-based setting utilizing longitudinal information.

16 Dec 2022

How do predicted ecological niches of the mpox virus compare with that of 99 mammal species?

Researchers compared ecological niches to identify probable mpox virus reservoir hosts.

15 Dec 2022

New approach to detect misinformation in an emergent health domain on social media

A paper coauthored by PhD student Lanyu Shang and members of Associate Professor Dong Wang's research group, the Social Sensing and Intelligence Lab in the School of Information Sciences at the University of Illinois Urbana-Champaign, received the best paper award in the research track during the 2022 IEEE/ACM International Conference on Advances in Social Network Analysis and Mining (ASONAM 2022).

13 Dec 2022

Overview of current methods, technologies, and applications in the molecular diagnosis of mpox

Researchers provided an overview of existing molecular methods for mpox virus detection.

13 Dec 2022

Knowledge and attitudes to mpox among GBMSM in Australia

Researchers presented the results of a cross-sectional survey done in Australia between August and September 2022.

12 Dec 2022

Reports of Mpox disease following recent vaccination

The risk of infection and development of severe symptoms for Mpox remains, even after vaccination

11 Dec 2022

Enveloped viruses show greater cross-species transmission, according to new research

New research found that enveloped viruses harbor greater cross-species transmissibility and are more likely to cause zoonotic infections than nonenveloped viruses.

9 Dec 2022

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Researchers from the University of Maine and University of Massachusetts Amherst have designed new liquid-coated air filters that allow for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.

7 Dec 2022

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Researchers evaluated the immunogenicity, boosting efficacy, and safety of single-dose and two-dose MVA-BN (modified vaccinia Ankara-Bavarian Nordic) vaccinations in comparison to replicating smallpox vaccines.

7 Dec 2022

Characterizing mpox cases among women in Spain

Researchers characterized mpox (formerly Monkeypox) cases among women in Spain between April and November 2022.

6 Dec 2022

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

A phase III clinical trial showed consistent immunogenicity for a freeze-dried formulation of Bavarian Nordic's Modified Vaccinia Ankara.

5 Dec 2022

Mpox virus from Clade 2b is the least virulent strain according to new study

Researchers used the CAST/EiJ mouse model to test whether genetic differences between clades 1, 2a, and 2b of the monkeypox virus contribute to changes in transmission and virulence of the disease.

5 Dec 2022

Much of the CDC is working remotely. That could make changing the agency difficult.

Earlier this year, top leadership at the Centers for Disease Control and Prevention began a monumental task: turning the sprawling, labyrinthine organization known for its highly specialized, academically focused scientific research into a sleek, flexible public health response agency primed to serve the American public.

5 Dec 2022

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers developed an mRNA technology-based vaccine candidate against the monkeypox virus and evaluated its immunogenicity in animal models.

5 Dec 2022

Mpox News and Research

Latest Mpox News and Research

Study suggests a single dose of JYNNEOS vaccine may lessen the severity of mpox illness

Diagnostic technologies in Asia Pacific are key to progress toward health-related SDGs

Novel mRNA-lipid nanoparticle vaccine encoding four mpox virus surface proteins generates robust immune responses against orthopoxviruses

Single-dose smallpox vaccine could be effective against mpox

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

Cryo-microscopy reveals high-resolution structure of monkeypox virus DNA polymerase holoenzyme

The mpox viral load kinetics over time in various parts of the body

How do predicted ecological niches of the mpox virus compare with that of 99 mammal species?

New approach to detect misinformation in an emergent health domain on social media

Overview of current methods, technologies, and applications in the molecular diagnosis of mpox

Knowledge and attitudes to mpox among GBMSM in Australia

Reports of Mpox disease following recent vaccination

Enveloped viruses show greater cross-species transmission, according to new research

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Characterizing mpox cases among women in Spain

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

Mpox virus from Clade 2b is the least virulent strain according to new study

Much of the CDC is working remotely. That could make changing the agency difficult.

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Mpox News and Research

Latest Mpox News and Research

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

Newsletters you may be interested in